R&D Think global, act local: rethinking commercialisation models The global market for life sciences is changing rapidly.
News Thread, Eversana join forces on real-world data platform Eversana's expansion into real-world data (RWD) handling has gathered pace via an alliance with Thread, a specialist in decentral
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.